Pharmafile Logo

A Successful Outing at ASH 2024

December 12, 2024 |  

- PMLiVE

Medscape has wrapped up their work at this year’s ASH annual meeting in San Diego. During the conference, Medscape hosted 8 symposia that presented the latest data and supported advancing person-centered care in Oncology and Hematology. Enduring programs from these education events will be posted online on Medscape.org soon.

Additionally, Medscape presented 3 posters which showed the impact of Medscape’s education programs on learner’s knowledge, competence, and confidence. The posters are available on the ASH conference website.

Throughout the event, Medscape had a focus on the power of patient-integration. Victoria Harvey-Jones, Associate Director of Clinical Strategy, and leader of Medscape’s Patient-Integration initiative, led the way with a poster created in collaboration with the Leukemia & Lymphoma Society.

Five of Medscape’s symposia were developed in collaboration with patient advocacy groups highlighting the increasing need to integrate lived experiences and the patient voice into medical education programming. This approach ensured a more holistic and impactful framework for content development. Two symposia featured patient advocates from the Lymphoma Coalition in DLBCL (diffuse large B-cell lymphoma) and FL (follicular lymphoma) as part of the faculty panel, while an advocate from the Cancer Support Community was present on a third symposia discussing ALL (acute lymphoblastic lymphoma). Two additional symposia were developed in partnership with the CLL Society and the National Bleeding Disorders Foundation.

“We were honored to work with patient advocates to bring people’s lived experience with DLBCL, FL and ALL/LBL to the forefront at ASH, and showcase the power of patient-integration in education to advance person-centered care. Taking this approach can be transformative for both patients and clinicians, and education is one of the best ways to reach them,” said Harvey-Jones.

Medscape will release an updated white paper on the power of patient-integration in 2025.

The AI pilot at the ASH conference booth was a success, showcasing cutting-edge technology in action. Attendees engaged with the AI-driven solution, gaining insights into its innovative capabilities and potential impact on advancing hematology education. The interactive demonstration generated significant interest, with attendees praising its usability and the potential to streamline clinical education. This pilot not only highlighted Medscape’s commitment to innovation but also gathered valuable feedback to refine the solution for broader implementation.

For more information on patient-integrated education, please contact Victoria Harvey-Jones at vharveyjones@webmd.net.
For more information on hematology education, please contact Christine Carey at ccarey@medscape.net

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

The Heart and Mouth Connection Every Woman Needs to Know

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...

Uncovering Inequities in Alzheimer’s Disease Screening and Care

  On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...

Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?

Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.

Does Rare Disease Education Work?

For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.

From Genetic Puzzles to Precision Therapeutics

How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more...

Medscape and the GNNRD: Empowering Nurses With a Rare Disease Education Series

Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care coordination, and ongoing education is essential to empower them to meet the...

What Is the RDI-Lancet Commission for Rare Disease and What Will It Achieve?

Christy Rohani-Montez, Medscape’s Rare Disease Education Lead recently spoke with Dr Lucy McKay, CEO, and Megan Pullein, Strategic Operations Officer from the UK-based charity Medics for Rare Disease (MfRD). We...

“CGM Sweet Talk With the Sugar Queens” Takes Silver at the 2025 Digital Health Awards

Medscape Education’s dynamic educational series, CGM Sweet Talk With the Sugar Queens, has earned a Silver Award in the Video Series (Digital Health Media / Publications) category at the 2025...

Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia

For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the...

Women Leaders Rewriting the Protocols of Rare Disease Care

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional and personal ethos of clinical immunologist Dr. Hilary...